Hardik Parikh
Stock Analyst at JP Morgan
(n/a)
# 4,711
Out of 5,124 analysts
5
Total ratings
20%
Success rate
-50.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Maintains: Overweight | $80 → $75 | $32.30 | +132.20% | 2 | Oct 24, 2025 | |
| PCRX Pacira BioSciences | Downgrades: Underweight | $45 → $10 | $25.31 | -60.49% | 2 | Aug 12, 2024 | |
| GPCR Structure Therapeutics | Initiates: Overweight | $65 | $63.24 | +2.78% | 1 | May 21, 2024 |
Viking Therapeutics
Oct 24, 2025
Maintains: Overweight
Price Target: $80 → $75
Current: $32.30
Upside: +132.20%
Pacira BioSciences
Aug 12, 2024
Downgrades: Underweight
Price Target: $45 → $10
Current: $25.31
Upside: -60.49%
Structure Therapeutics
May 21, 2024
Initiates: Overweight
Price Target: $65
Current: $63.24
Upside: +2.78%